Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



fertilisation1 - pelvic inflammatory disease2 - resistant bacteria1 - genital tract1 - focal glomerulosclerosis2 - protein flt11 - psa level1 - the scientific registry of transplant recipients1 - severe urinary incontinence1 - prostate-specific antigen screening1 - intrauterine devices1 - renal calculi1 - nephrectomy2 - hyperglycemia1 - vagina4 - medullary cystic disease1 - cihi1 - nongonococcal urethritis2 - phospho-proteomics1 - ckd progression1 - matrix calculus3 - nocturnal enuresis3 - bladder defects1 - kidney health3 - tgen1 - malignant cancer1 - high blood sugar1 - autosomal dominant polycystic kidney disease1 - burning2 - testis1 -